Found 6 matching trials
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC PHASE2 This will be an open-label, phase 2 study in which subjects will receive IS...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma PHASE2 This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer PHASE2 The goal of this clinical research study is to learn if utomilumab, when gi...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy PHASE2 The primary objective of the study is to estimate the clinical benefit of c...
Show More Location
Arizona Oncology Associates
Learn More & Join Trial
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC PHASE2 This will be a blinded, placebo-controlled, randomized, phase 2 study in wh...
Show More Learn More & Join Trial
Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer PHASE1 The purpose of the study is to assess the safety, tolerability and the HPV-...
Show More Learn More & Join Trial